Specifically, higher levels of CST2 expression were observed in the advanced stages of STAD, ACC, BRCA, OV, UCS, LUSC, KIRC, BLCA, THCA, and COAD (Figure 1E). This evidence concerns the gene CST2 and adrenal cortex carcinoma.